Milan

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Thyroid cancer2 trials
• Bladder cancer1 trial
• Childhood cancers1 trial
• Colorectal cancer1 trial
• Endometrial cancer1 trial
• Gastric and oesophageal cancer1 trial
• Head and neck cancer1 trial
• Kidney cancer1 trial
• Liver and biliary tract cancer1 trial
• Lung cancer1 trial
• Ovarian cancer1 trial
• Prostate cancer1 trial
• and 1 more

Phase

• Phase 11 trial
• Phase 31 trial

Status

• Active, not recruiting2 trials

Lead sponsor

• Exelixis2 trials

Running trials

• Active, not recruiting

  A Study of Cabozantinib Compared With Placebo in Subjects With Radioiodine-refractory Differentiated Thyroid Cancer Who Have Progressed After Prior Vascular Endothelial Growth Factor Receptor (VEGFR) -Targeted Therapy

  NCT03690388· Phase 3· Exelixis· Source

• Active, not recruiting

  Study of Cabozantinib Alone or in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors

  NCT03170960· Phase 1· Exelixis· Source